货币 / CLDX
CLDX: Celldex Therapeutics Inc
22.08
USD
0.30
(1.34%)
今日CLDX汇率已更改-1.34%。当日,交易品种以低点21.71和高点23.02进行交易。
关注Celldex Therapeutics Inc动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CLDX新闻
- Celldex: Despite Dropping Eosinophilic Esophagitis Program, Barzolvolimab On Track (CLDX)
- Why Is Celldex Therapeutics Stock Falling Today - Celldex Therapeutics (NASDAQ:CLDX)
- La-Z-Boy Posts Downbeat Q1 Results, Joins James Hardie Industries, Alcon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Celldex Therapeutics (NASDAQ:CLDX), Alcon (NYSE:ALC)
- Stifel reiterates Buy rating on Celldex stock despite EoE setback
- H.C. Wainwright reiterates Buy rating on Eupraxia Pharmaceuticals stock
- Why Rocket Pharmaceuticals Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Color Star Tech (NASDAQ:ADD), Aspen Insurance Hldgs (NYSE:AHL)
- Celldex stock price target lowered to $62 at Canaccord on EoE program halt
- Celldex stock price target lowered to $42 by H.C. Wainwright
- Celldex stock falls as Wells Fargo cuts price target on EOE trial failure
- Celldex’s mast cell therapy fails to improve eosinophilic esophagitis
- Celldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates
- Celldex Therapeutics earnings beat by $0.01, revenue fell short of estimates
- scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?
- Jasper Therapeutics stock holds Market Outperform rating at JMP despite setback
- Celldex stock price target maintained at $50 by H.C. Wainwright
- Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
- Crude Oil Rises 6%; US Consumer Sentiment Surges In June - Senmiao Tech (NASDAQ:AIHS), Chanson International (NASDAQ:CHSN)
- Celldex shares jump on impressive skin disorder drug data
- Visa, Mastercard lead Friday’s market cap stock movers
- Unusual Machines, Celldex Therapeutics, RH And Other Big Stocks Moving Higher On Friday - Bunge Global (NYSE:BG), AleAnna (NASDAQ:ANNA)
- Celldex stock maintains Overweight rating on promising CSU therapy results
- Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025
- Celldex stock rating reiterated at Buy by Canaccord ahead of data release
- Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress
日范围
21.71
23.02
年范围
14.40
46.90
- 前一天收盘价
- 22.38
- 开盘价
- 22.52
- 卖价
- 22.08
- 买价
- 22.38
- 最低价
- 21.71
- 最高价
- 23.02
- 交易量
- 2.143 K
- 日变化
- -1.34%
- 月变化
- 1.24%
- 6个月变化
- 3.81%
- 年变化
- -45.82%
30 八月, 星期六